Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Recruiting	Phase 1 / Phase 2	2026-09-08		NCT07002320

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Belfast Health and Social Care Trust	16
Cambridge University Hospitals NHS Foundation Trust	64
Institute of Cancer Research, United Kingdom	59
Institute of Oncology Research (IOR)	1
Janssen Pharmaceutica N.V., Belgium	13
Oncology Institute of Southern Switzerland	12
Prostate Cancer UK	4
Royal Marsden NHS Foundation Trust	89
Syntrix Biosystems, Inc.	9

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Belfast Health and Social Care Trust	Belfast	United Kingdom	5
Cambridge University Hospitals NHS Foundation Trust	Cambridge	United Kingdom	34
Oncology Institute of Southern Switzerland	Bellinzona	Switzerland	1
The Royal Marsden NHS Foundation Trust - Drug Development Unit	Sutton	United Kingdom	2